Canakinumab Lacks Efficacy in Treating Adult Patients with Moderate to Severe Chronic Spontaneous Urticaria in a Phase II Randomized Double-Blind Placebo-Controlled Single-Center Study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Canakinumab Lacks Efficacy in Treating Adult Patients with Moderate to Severe Chronic Spontaneous Urticaria in a Phase II Randomized Double-Blind Placebo-Controlled Single-Center Study

Published:2021-01 Issue:1 Volume:9 Page:463-468.e3
ISSN:2213-2198
Container-title:The Journal of Allergy and Clinical Immunology: In Practice
language:en
Short-container-title:The Journal of Allergy and Clinical Immunology: In Practice

Author:

Maul Julia-Tatjana,Distler Meike,Kolios Antonios,Maul Lara Valeska,Guillet Carole,Graf Nicole,Imhof Laurence,Lang Claudia,Navarini Alexander A.,Schmid-Grendelmeier Peter

Funder

Novartis Pharma Switzerland

AbbVie

Almirall

Amgen

BMS

Celgene

Eli Lilly

LEO Pharma

Janssen-Cilag

MSD

Novartis

Pfizer

Pierre Fabre

Roche

Sanofi

Promedica and Bruno-Bloch Foundation

Publisher

Elsevier BV

Subject

Immunology and Allergy

Reference26 articles.

1. Unmet clinical needs in chronic spontaneous urticaria. A GA(2)LEN task force report;Maurer;Allergy,2011

2. Epidemiology of urticaria in Spain;Gaig;J Investig Allergol Clin Immunol,2004

3. The EAACI/GA(2)LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria;Zuberbier;Allergy,2018

4. Pathogenesis of chronic urticaria;Kaplan;Clin Exp Allergy,2009

5. What the first 10,000 patients with chronic urticaria have taught me: a personal journey;Kaplan;J Allergy Clin Immunol,2009

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Quality of life measurement in assessing treatment effectiveness in urticaria: European experts position statement;International Journal of Dermatology;2024-07-04

2. Quality of life measurement in urticaria: Position statement of the European Academy of Dermatology and Venereology Task Forces on Quality of Life and Patient‐Oriented Outcomes and Urticaria and Angioedema;Journal of the European Academy of Dermatology and Venereology;2024-06-10

3. Journal club: Recent therapeutic developments in the management of chronic spontaneous urticaria;European Journal of Dermatology;2023-06

4. A systematic review of 454 randomized controlled trials using the Dermatology Life Quality Index: experience in 69 diseases and 43 countries;British Journal of Dermatology;2023-03-27

5. Inhibition of interleukin‐1 with rilonacept is not effective in cold urticaria—Results of a randomized, placebo‐controlled study;Clinical and Translational Allergy;2023-02-28

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3